177Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing 177Lu-PSMA-I&T Therapy.
| Autor: | John, Nikeith, Pathmanandavel, Sarennya, Crumbaker, Megan, Counter, William, Bao Ho, Yam, Andrew O., Wilson, Peter, Niman, Remy, Ayers, Maria, Poole, Aron, Hickey, Adam, Agrawal, Shikha, Perkins, Gary, Kallinen, Annukka, Eslick, Enid, Stockler, Martin R., Joshua, Anthony M., Nguyen, Andrew, Emmett, Louise |
|---|---|
| Zdroj: | Journal of Nuclear Medicine; Mar2023, Vol. 64 Issue 3, p410-415, 6p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|